These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Recent Developments in the Principles, Modification and Application Prospects of Functionalized Ethosomes for Topical Delivery. Lu J; Guo T; Fan Y; Li Z; He Z; Yin S; Feng N Curr Drug Deliv; 2021; 18(5):570-582. PubMed ID: 32851961 [TBL] [Abstract][Full Text] [Related]
83. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs. McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420 [TBL] [Abstract][Full Text] [Related]
84. Phospholipid and menthol based nanovesicle impregnated transdermal patch for nutraceutical delivery to diminish folate and iron deficiency. Kumari D; Bhatia E; Awasthi L; Banerjee R Biomed Mater; 2022 May; 17(4):. PubMed ID: 35168221 [TBL] [Abstract][Full Text] [Related]
85. Large Size Microneedle Patch to Deliver Lidocaine through Skin. Kathuria H; Li H; Pan J; Lim SH; Kochhar JS; Wu C; Kang L Pharm Res; 2016 Nov; 33(11):2653-67. PubMed ID: 27401408 [TBL] [Abstract][Full Text] [Related]
86. Successful application of large microneedle patches by human volunteers. Ripolin A; Quinn J; LarraƱeta E; Vicente-Perez EM; Barry J; Donnelly RF Int J Pharm; 2017 Apr; 521(1-2):92-101. PubMed ID: 28216463 [TBL] [Abstract][Full Text] [Related]
87. Conductive polymer nanotube patch for fast and controlled ex vivo transdermal drug delivery. Nguyen TM; Lee S; Lee SB Nanomedicine (Lond); 2014 Oct; 9(15):2263-72. PubMed ID: 24405462 [TBL] [Abstract][Full Text] [Related]
88. What is the future of heated transdermal delivery systems? Otto DP; de Villiers MM Ther Deliv; 2014; 5(9):961-4. PubMed ID: 25375338 [No Abstract] [Full Text] [Related]
89. Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin. Demir YK; Akan Z; Kerimoglu O PLoS One; 2013; 8(5):e63819. PubMed ID: 23675508 [TBL] [Abstract][Full Text] [Related]
90. Dissolving microneedles for transdermal drug delivery: Advances and challenges. Ita K Biomed Pharmacother; 2017 Sep; 93():1116-1127. PubMed ID: 28738520 [TBL] [Abstract][Full Text] [Related]
91. Design and Evaluation of Transdermal Patches of Timolol Maleate. Panchayya Hiremath SS; Reddy JJ; Jamakandi VG Curr Drug Deliv; 2018; 15(5):658-663. PubMed ID: 28969565 [TBL] [Abstract][Full Text] [Related]
92. Nanoparticle delivery for transdermal HRT. Valenzuela P; Simon JA Maturitas; 2012 Sep; 73(1):74-80. PubMed ID: 22325243 [TBL] [Abstract][Full Text] [Related]
93. The transdermal delivery of fentanyl. Lane ME Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814 [TBL] [Abstract][Full Text] [Related]
94. Individually coated microneedles for co-delivery of multiple compounds with different properties. Li S; Li W; Prausnitz M Drug Deliv Transl Res; 2018 Oct; 8(5):1043-1052. PubMed ID: 29948917 [TBL] [Abstract][Full Text] [Related]
95. Microneedle patch designs to increase dose administered to human subjects. Li W; Li S; Fan X; Prausnitz MR J Control Release; 2021 Nov; 339():350-360. PubMed ID: 34597745 [TBL] [Abstract][Full Text] [Related]
96. Nanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue Targeting. Palmer BC; DeLouise LA Molecules; 2016 Dec; 21(12):. PubMed ID: 27983701 [TBL] [Abstract][Full Text] [Related]
97. An overview on the advantages and limitations of 3D printing of microneedles. Ozyilmaz ED; Turan A; Comoglu T Pharm Dev Technol; 2021 Nov; 26(9):923-933. PubMed ID: 34369288 [TBL] [Abstract][Full Text] [Related]
98. Enhanced transdermal drug delivery techniques: an extensive review of patents. Rizwan M; Aqil M; Talegaonkar S; Azeem A; Sultana Y; Ali A Recent Pat Drug Deliv Formul; 2009 Jun; 3(2):105-24. PubMed ID: 19519571 [TBL] [Abstract][Full Text] [Related]
99. Role of pressure-sensitive adhesives in transdermal drug delivery systems. Lobo S; Sachdeva S; Goswami T Ther Deliv; 2016; 7(1):33-48. PubMed ID: 26652621 [TBL] [Abstract][Full Text] [Related]
100. Use of transdermal drug formulations in the elderly. Kaestli LZ; Wasilewski-Rasca AF; Bonnabry P; Vogt-Ferrier N Drugs Aging; 2008; 25(4):269-80. PubMed ID: 18361538 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]